Pages

Subscribe:

Ads 468x60px

Monday, November 24, 2014

Pinor (Imipramine)






Pinor (Imipramine)

Therapeutic Group: Antipsychotic, Neurotonic & Sedative



Generic: Imipramine

Presentation:
Pinor Tablet: Each tablet contains Imipramine HCl USP 25 mg.

Pharmacology:
Imipramine is the prototype of the tricyclic class of antidepressants. It is a potent inhibitor of norepinephrine reuptake at noradrenergic nerve endings. It is also an inhibitor of 5-hydroxytrytamine (5-HT) reuptake but these effects are less marked than those on norepinephrine. Imipramine is a competitive antagonist at alfa-adrenoceptors but the effects are relatively weak.

Indication:
Treatment of depression, management of panic disorder, management of pain, management of enuresis, treatment of hyperactivity and attention deficit.

Dosage & Administration:
Depression: Initially up to 75 mg daily in divided doses increased gradually to 150-200 mg (up to 300 mg in hospital); up to 150 mg may be given as a single dose at bed time; Elderly: initially 10 mg daily, increased gradually to 30-50 mg daily; child not recommended for depression. Nocturnal enuresis: Child: 7 years, 25 mg; 8-11 years 25-50 mg, over 11 years, 50-75 mg at bedtime; max. period of treatment (Including gradual withdrawal) is 3 months;full physical examination is required before further course. Panic attack: Initially 10-25 mg/day, depending on how the medication is tolerated, raise the dose until the desired response is obtained. The daily doses required vary greatly from patient to patients, between 75-150 mg, if necessary it can be increased to 200 mg. Chronic painful condition: The dosage must be individualized (25-300 mg daily). A daily dose of 25-75 mg is generally sufficient.

Contraindications:
Recent myocardial infarction, arrhythmias (particularly heart block), not indicated in manic phase, severe liver disease.

Warning & Precautions:
Cardiac diseases (particularly with arrhythmias), history with epilepsy, pregnancy and breast feeding, elderly, hepatic impairment (avoid if severe), thyroid disease, psychoses, angle-closure glaucoma, history of urinary retention, concurrent electro-convulsive therapy.

Drowsiness may affect performances of skilled tasks (e.g. driving), alcohol induced Imipramine effect.

Side Effects:
Dry mouth, less sedation, blurred vision (disturbances of accommodation, increased intraocular pressure), constipation, nausea, difficulty with micturation; cardiovascular side-effects, sweating, tremors, rashes and hypersensitivity reaction (including urticaria & photosensitivity), behavioral disturbances (particularly in children) hypomania or mania (particularly in elderly), interference with sexual function; blood sugar changes, increased appetite, weight gain (occasionally weight loss).

Drug interaction:
Imipramine should not be used in combination with Monoamine oxidase inhibitors (MAO), anticholinergic agents, antihypertensive agents, methylphenidate, levodopa, antipsychotic drug, cimetidine, barbiturates, and oral contraceptives.

Packing:
Pinor Tablet: Each box contains 50's tablets in blister pack.






Notens (Bromazepam)





Notens (Bromazepam)

Therapeutic Group: Antipsychotic, Neurotonic & Sedative
Generic: Bromazepam

Presentation:
Notens Tablet: Each tablet contains bromazepam BP 3 mg.

Pharmacology:
Bromazepam is a benzodiazepine with anxiolytic and sedative properties, which are of value in the symptomatic relief of pathological anxiety in psychoneurotic patients. The absolute bioavailability of unchanged, orally administered bromazepam is 60%, and peak blood levels are achieved within 2 hours after administration. On average, 70% of bromazepam is bound to plasma proteins. Bromazepam is metabolized in the liver, and has an elimination half-life of 20 hours (the half-life may be longer in elderly patients). The metabolites are excreted in the urine as conjugated form. Bromazepam binds to specific site on the GABA, an important inhibitory neurotransmitters in the CNS, which acts by opening chloride ion channel into the cells.

Indication:
Emotional disturbances: Acute tension and anxiety states, difficulties in interpersonal contacts, agitation, insomnia, anxious and agitated depressive reaction.
In the cardiovascular and respiratory system: Pseudoangina pectoris, precordial anxiety, tachycardia, emotiogenic hypertension, dyspnoea, and hyperventilation.
In the gastrointestinal system: Irritable bowel syndrome, epigastric pain, spasm, bloating, diarrhoea.
In the genitourinary system: Frequency, irritable bladder and dysmenorrhoea.
Psychosomatic disorders: Psychogenic headache, psychogenic dermatoses, asthma, gastric and duodenal ulcer, and ulcerative colitis. Emotional reactions to chronic organic disease. Adjuvant to psychotherapy in psychoneurosis.

Dosage & Administration:
Usual dose for anxiety is 3 to 18 mg daily in divided dose. Higher doses up to 60 mg have occasionally been given to hospitalized patients. Dose should be reduced at least half in elderly patients and those with hepatic and renal impairment.

Contraindications:
In patients with known hypersensitivity to benzodiazepines, myasthenia gravis, severe hepatic insufficiency, severe respiratory insufficiency, or sleep apnoea syndrome.

Warning & Precautions:
Bromazepam is not recommended for use in patients with depressive disorders or psychosis. Patients should be advised against the concurrent use of alcohol and other CNS depressant drugs. Patients with known or presumed dependence from alcohol or drugs should not take benzodiazepines.
Since bromazepam has a CNS depressant effect, patients should be warned against driving, operating dangerous machinery, or engaging in other hazardous activities requiring mental alertness and physical coordination.

Side Effects:
Drowsiness and lightheadedness the next day; confusion and ataxia (specially in the elderly); amnesia may occur; dependence; paradoxical increase in aggression; occasionally headache, vertigo, hypotension, salivation changes, gastrointestinal disturbances, visual disturbances, dysarthria, tremor, changes in libido, incontinence, urinary retention, blood disorders and jaundice reported.

Drug interaction:
Bromazepam may potentiate or interact with the effects of other CNS acting drugs such as alcohol, narcotics, hypnotics, sedative antihistamines, antipsychotics, anxiolytics/sedatives, anesthetics, antidepressants and anticonvulsants. Therefore, if bromazepam is to be combined with other drugs acting on the CNS, careful consideration should be given to the pharmacology of the agent involved because of possible additive or potentiation of drug effects.

Use in Special group:
Use in pregnancy: The safety of using bromazepam in pregnancy has not been established. Therefore, bromazepam should not be used during pregnancy.
Use in lactation: Bromazepam and its metabolites are probably excreted in human milk. Therefore, this drug should not be given to nursing mothers.
Use in children: Because of the lack of sufficient clinical experience, bromazepam is not recommended for use in patients less than 18 years of age.

Packing:
Notens Tablet: Each box contains 50's tablets in blister pack.








Evalin (Diazepam)



Evalin (Diazepam)

Therapeutic Group: Antipsychotic, Neurotonic & Sedative

Generic: Diazepam

Presentation:
Evalin Tablet: Each tablet contains Diazepam BP 5 mg.

Pharmacology:
Diazepam is a benzodiazepine that is very widely used for its sedative, hypnotic, anxiolytic, muscle relaxant and anticonvulsant properties. Diazepam, like other members of the benzodiazepine family, binds to receptors in various regions of the brain, such as the spinal cord, brain stem, cerebellum, limbic system and cerebral cortex. Binding of diazepam to the benzodiazepine receptor potentiates the inhibitory actions of gamma-aminobutyric acid (GABA) mediated through chloride channel, thereby enhancing GABA-facilitated, inhibitory synaptic transmission.

Indication:
Anxiety, skeletal muscle spasm, emotionally stressful condition, status epilepticus and other convulsive states (tetanus, eclampsia), excitation states, surgical procedures, night terrors & walking sleeping.

Dosage & Administration:
Usual dose for anxiety is 2 mg three times daily increased if necessary to 15-30 mg in divided dose; Elderly half dose of adult. Insomnia associated with anxiety, 5-15 mg at bedtime. Child: Night terrors and walking sleep, 1-5 mg at bedtime.

Contraindications:
Patients with known hypersensitivity to benzodiazepines, & myasthenia gravis are contraindicated to diazepam.

Warning & Precautions:
Diazepam is not recommended for use in patients with depressive disorders or psychosis. Patients should be advised against the concurrent use of alcohol and other CNS depressant drugs. Patients with known or presumed dependence from alcohol or drugs should not take benzodiazepines.
Since Diazepam has a CNS depressant effect, patients should be warned against driving, operating dangerous machinery, or engaging in other hazardous activities requiring mental alertness and physical coordination.

Side Effects:
Drowsiness and light headedness the next day; confusion and ataxia (specially in the elderly); amnesia may occur; dependence; paradoxical increase in aggression; occasionally headache, vertigo, hypotension, gastrointestinal disturbances, visual disturbances, dysarthria, tremor, changes in libido, incontinence, urinary retention, blood disorders and jaundice reported.

Drug interaction:
Diazepam may potentiate or interact with the effects of other CNS acting drugs such as alcohol, narcotics, hypnotics, sedative antihistamines, antipsychotics, anxiolytics/sedatives, anesthetics, antidepressants and anticonvulsants. Besides these diazepam may interact with phenytoin, cimetidine, levodopa, lithium.

Use in Special group:
Use in pregnancy: Several studies have suggested an increased risk of congenital malformation associated with the use of diazepam during the first trimester of pregnancy. The expected therapeutic benefit for the mother should be weighed against the possible risk to the fetus before diazepam is administered to a pregnant woman.
Use in lactation: Diazepam and its metabolites are probably excreted into human milk. So, it should be avoided during breast-feeding.

Packing:
Evalin Tablet: Each box contains 500's tablets in blister pack.





Dormax (Midazolam)





Dormax (Midazolam)

Therapeutic Group: Antipsychotic, Neurotonic & Sedative

Generic: Midazolam BP

Presentation:
Dormax Tablet : Each film coated tablet contains Midazolam Maleate equivalent to Midazolam BP 7.5 mg.
Dormax IV/IM Injection : Each 3 ml ampoule contains Midazolam Hydrochloride equivalent to Midazolam BP 15 mg.

Pharmacology:
Midazolam is a water-soluble benzodiazepine derivative characterized by rapid onset and short duration of action. It has anxiolytic, sedative, hypnotic and anticonvulsant characteristics as well as possible muscle relaxant characteristic.

Indication:
1. Short-term management of insomnia, 2. Conscious/Procedural sedation prior to or during diagnostic, therapeutic or endoscopic procedures such as dentistry, upper gastrointestinal endoscopy, bronchoscopy, cystoscopy, coronary angiography and cardiac catheterization, oncology procedures, radiologic procedures, suture of lacerations etc. and surgery performed under local anesthesia, either alone or in combination with other CNS depressants, 3. Premedication, 4. Induction of general anesthesia, 5. Sedation in intensive care, 6. Sedation in general anesthesia, 7. Status epilepticus.

Dosage & Administration:
Dosage :
Short-term management of insomnia :
Adults: 7.5-15 mg daily orally. In patients with impaired liver function & in elderly and debilitated patients, the recommended daily dose is 7.5 mg. Treatment should be started with the lowest recommended dose and continued for as short time as possible, usually max. for 2 weeks. Dormax can be taken at any time of the day if the patient can subsequently take undisturbed sleep for at least 7-8 hrs.
Children: Not recommended.
Conscious/Procedural Sedation :
Adults : By slow IV injection, initially 2–2.5 mg (elderly 0.5–1 mg) at a rate of approx. 2 mg/minute 5–10 minutes before procedure, increased if necessary in steps of 1 mg (elderly 0.5–1 mg); usual total dose 3.5–5 mg (max. 7.5 mg, elderly 3.5 mg).
Children : By slow IV injection, initially 0.025-0.05 mg/kg over 2-3 minutes 5-10 minutes before procedure, increased if necessary in small step. Age wise maximum doses are as follows-
1 month–6 yrs: 6 mg; 6–12 yrs: 10 mg; 12–18 yrs: 7.5 mg.
By mouth, child 1 month–18 yrs, 0.5 mg/kg (max. 20 mg) 30-60 minutes before procedure
By buccal administration, child 6 months–10 yrs, 0.2-0.3 mg/kg (max. 5 mg); child 10-18 yrs, 6-7 mg (max. 8 mg if 70 kg or over).
By rectum, child 6 months–12 yrs, 0.3-0.5 mg/kg 15-30 minutes before procedure.
N.B. Dormax Injection solution can be given by buccal with a syringe without needle & rectal administration with a rectal applicator.
Premedication :
Adults : By mouth, 15 mg 30-60 minutes before procedure.
By deep IM injection, 0.07–0.1 mg/kg (elderly or debilitated 0.025–0.05 mg/kg) 20–60 minutes before procedure.
By IV injection, 1–2 mg 5–30 minutes before procedure, repeated as required (elderly or debilitated 0.5 mg, repeated slowly as required).
Children : By mouth, 15-30 minutes before procedure, child 1 month–18 years, 0.5 mg/kg (max. 20 mg).
By IV injection, child 12–18 years, 0.025-0.05 mg/kg repeated as required (max. 7.5 mg).
By rectum, child 6 months–12 years, 0.3-0.5 mg/kg 15-30 minutes before procedure.
N.B. Dormax Injection solution can be given by rectal administration with a rectal applicator.
Induction of general anesthesia :
Midazolam is used IV prior to administration of other anesthetic agents.
By slow IV injection; adult, 0.15–0.2 mg/kg (elderly or debilitated 0.05–0.15 mg/kg) given in divided doses (max. 5 mg) at intervals of 2 minutes; max. total dose 0.6 mg/kg; child 7–18 years, initially 0.15 mg/kg (max. 7.5 mg) given in steps of 0.05 mg/kg (max. 2.5 mg) over 2–5 minutes; wait for 2–5 minutes then give additional doses of 0.05 mg/kg (max. 2.5 mg) every 2 minutes if necessary; max. total dose 0.5 mg/kg (not exceeding 25 mg).
Sedation in intensive care :
Adult: By slow IV injection, initially 0.03–0.3 mg/kg given in steps of 1–2.5 mg every 2 minutes, then by slow IV injection or by continuous IV infusion, 0.03–0.2 mg/kg/hr; reduce dose (or reduce or omit initial dose) in hypovolemia, vasoconstriction, or hypothermia; lower doses may be adequate if opioid analgesic also used.
Children: Neonate under 32 wks of gestational age, by continuous IV infusion, 0.03 mg/kg/hr; neonate over 32 wks of gestational age and child under 6 months , by continuous IV infusion, 0.06 mg/kg/hr; child 6 months-12 yrs, by slow IV injection , initially 0.05–0.2 mg/kg over at least 3 minutes followed by 0.03–0.12 mg/kg/hr by continuous IV infusion; child 12-18 yrs, as recommended for adults. Doses for children should be adjusted according to response.
Sedation in general anaesthesia :
Adults: By IV injection, 0.03–0.1 mg/kg repeated as required or by continuous IV infusion, 0.03–0.1 mg /kg/hour (elderly, lower doses needed); child not recommended.
Status Epilepticus :
By buccal administration: The dose can be repeated once after 10 minutes if necessary. Adult & children over 10 yrs, 10 mg; Child up to 6 months, 0.3 mg/kg (max. 2.5 mg); 6 months-1 yr, 2.5 mg; 1-5 yrs, 5 mg; 5-10 yrs, 7.5 mg.
N.B. Dormax Injection solution can be may be given by buccal administration in the management of status epilepticus.
Administration :
For administration to children by mouth, injection solution may be diluted with apple juice, chocolate sauce, or cola.
For buccal administration, administer half of the dose between the upper lip and gum on each side of the mouth using an oral syringe; retain in the mouth for at least 5 minutes then swallow.
For continuous intravenous infusion, dilute with Glucose 5% or Sodium Chloride 0.9%; for neonates and children under 15 kg body-weights, dilute to a max. concentration of 1 mg/ml.

Contraindications:
1. Known hypersensitivity to benzodiazepines or any component of the product, 2. Respiratory insufficiency including unstable myasthenia gravis, 3. Sleep apnea syndrome, 4. Severe hepatic insufficiency. 5. Acute narrow-angle glaucoma. 6. Co-administration of any strong inhibitor of CYP3A4 isoenzyme e.g. oral ketoconazole & itraconazole

Warning & Precautions:
Treatment of insomnia with Dormax may lead to the development of physical & psychological dependence. In this case, if treatment needs to be discontinued, it should be done by tapering the dose in order to avoid withdrawal symptoms or rebound insomnia. Tapering should be tailored to individual. Sedation, amnesia, impaired concentration and impaired muscular function may adversely affect the ability to drive or to use machines specially when sleep duration is insufficient. Coma can be precipitated in patients with hepatic impairment; Caution should be taken in this case. Start with small doses in severe impairment; increased cerebral sensitivity.

Side Effects:
Gastro-intestinal disturbances, jaundice, drowsiness, ataxia, amnesia, euphoria,, headache, dizziness, involuntary movements, urinary retention, incontinence, muscle weakness. Thrombophlebitis, thrombosis, local erythema, induration may arise at injection site. Some side effects are observed particularly with high doses of IV/IM injection (single dose of 10 mg or above) or on rapid injection for example, hypotension, cardiac arrest, respiratory depression & arrest.

Drug interaction:
The metabolism of Midazolam is predominantly mediated by CYP3A4 isoenzyme. That’s why concomitant administration of Midazolam is not recommended with strong inhibitor of CYP3A4 isoenzyme e.g. oral ketoconazole and itraconazole. Moderate inhibitors of CYP3A4 isoenzyme e.g. protease inhibitors, nefazodone, sertraline, grapefruit juice, fluoxetine, erythromycin, diltiazem, clarithromycin inhibit the metabolism of midazolam, leading to a prolonged action. Moderate inducers of CYP3A4 isoenzyme e.g. rifampin, rifabutin, phenytoin enhance the metabolism of Midazolam, leading to a reduced action. Sedating antidepressants, antiepileptic drugs such as phenobarbital, phenytoin and carbamazepine, sedative antihistamines, opiates, antipsychotics and alcohol enhance the sedative effects of Midazolam. It is better not to administer Midazolam with these drugs but if there is clear need of co-administration, dose of either or both of the drugs may need to be adjusted.

Use in Special group:
Use in pregnancy : Avoid regular use (risk of neonatal withdrawal symptoms); use only if clear indication such as seizure control. Like all Benzodiazepines, high doses of Midazolam during late pregnancy or labor may cause neonatal hypothermia, hypotonia & respiratory depression; use only if clear indication exists or benefit outweigh the risk.
Use in lactation : Since Midazolam passes into breast milk, Dormax should not be administered to breast-feeding mothers.

Packing:
Dormax Tablet : Each box contains 20/30/50 tablets in blister pack.
Dormax IV/IM Injection : Each box contains 1/2/3/5 ampoule.







Arotril...... (Clonazepam)





Arotril

 (Clonazepam)
Therapeutic Group: Antipsychotic, Neurotonic & Sedative













Generic: Clonazepam

Presentation:
Arotril 0.5 mg Tablet: Each tablet contains Clonazepam USP 0.5 mg.
Arotril 1 mg Tablet: Each tablet contains Clonazepam USP 1 mg.
Arotril 2 mg Tablet: Each tablet contains Clonazepam USP 2 mg.

Pharmacology:
Arotril (Clonazepam), a derivative of benzodiazepine is mainly used as anticonvulsant drug. Clonazepam brings about direct inhibition of cortical and sub-cortical epileptogenic focus and thus prevents the formation of convulsive activity. It displays several pharmacological properties, which are characteristics of benzodiazepine class of drugs. At the spinal cord level clonazepam depresses more reflux pathways and potentiates presynaptic inhibition of GABA in the CNS. Overcompensatory excitation processes are thereby reduced via negative feedback without substantiation of other physiologic neuronal activity.

Indication:
1. Epilepsy: Status epilepticus, Lennox-Gastaut syndrome, Infantile spasms, Absences seizure, Myoclonic seizures, Tonic - clonic seizures, Akinetic and atonic seizures & Partial seizures 2. Drug- induced dyskinesias 3. Fulgurant pain 4. Bipolar affective disorder 5. Choreiform movements 6. Panic attacks

Dosage & Administration:
The standard dose of clonazepam must be individually adjusted according to the patient’s clinical response and tolerance of the drug. As a general rule, clonazepam is started with low single dose in a new patient.
Adults: 1mg (elderly, 0.5mg), initially at night for 4 nights, increased according to response over 2-4 weeks to usual maintenance dose of 4-8mg which is usually given at night as a single dose or may be given in 3-4 divided doses if necessary.
Children: Up to 1 year, initially 0.25 mg, increased as above to usual maintenance dose of 0.5-1 mg, 1-5 years initially 0.25 mg, increased as above to 1-3 mg, 5-12 years, initially 0.5 mg, increased as above to 3-6 mg.

Contraindications:
Clonazepam must not be used in patients with known hypersensitivity to any components of this preparation, in patients dependent on medications, drugs of abuse or alcohol, or suffering from myasthenia gravis.

Warning & Precautions:
The dosages of Clonazepam must be carefully adjusted to individual requirements in elderly patients, patients with pre-existing diseases of liver, kidney & respiratory system (e.g. chronic obstructive pulmonary disease) or undergoing treatment with other centrally acting medications. Special care should be taken while administering clonazepam in patients with spinal or cerebellar ataxia and in the event of acute intoxication with alcohole other centrally acting medications and analgesics.

Side Effects:
Side effects like tiredness, sleepiness, muscular hypotonia, dizziness, co-ordination disturbance, hyper salivation in infants, paradoxical aggression, irritability, light-headache and ataxia may occur. These effects are usually transients and generally disappear spontaneously in the course of treatment or on the reduction of dosage.

Drug interaction:
Narcotics, barbiturates, non-barbiturates, hypnotics, anti-anxiety agents, MAO inhibitors, tricyclic antidepressant and anticonvulsant drugs may potentiate the CNS-depressant action of clonazepam.

Use in Special group:
The use of clonazepam during pregnancy or lactation should be avoided. The drug should only be administered to pregnant woman if the potential benefits of the patient outweigh the risk of fetus. Nursing mother must stop breast-feeding while taking clonazepam or vise versa. 

Packing:
Arotril 0.5 mg Tablet: Each box contains 100's tablets in blister pack.
Arotril 1 mg Tablet: Each box contains 50's tablets in blister pack.
Arotril 2 mg Tablet: Each box contains 30's tablets in blister pack.




Sunday, November 23, 2014

Anfree ....((Flupentixol + Melitracen))




Anfree 

(Flupentixol + Melitracen)
Therapeutic Group: Antipsychotic, Neurotonic & Sedative

Generic:
Flupentixol & Melitracen

Presentation:
Anfree Tablet: Each tablet contains Flupentixol Dihyrochloride BP equivalent to Flupentixol 0.5 mg and Melitracen Hydrochloride INN equivalent to Melitracen 10 mg.

Pharmacology:
Flupentixol-a neuroleptic with anxiolytic and antidepressant properties of its own when given in small doses, and Melitracen - a bipolar thymoleptic with activating properties in low doses. In combination, the compounds render a preparation with antidepressant, anxiolytic and activating properties.
Maximal serum concentration is reached in about 4 hours after oral administration of Flupentixol and in about 4 hours after oral administration of Melitracen. The biological half-life of Flupentixol is about 35 hours and that of Melitracen is about 19 hours. The combination of Flupentixol and Melitracen does not seem to influence the pharmacokinetic properties of the individual compounds.

Indication:
Different types of anxiety, depression & apathy. These include- psychogenic depression, depressive neuroses, masked depression, psychosomatic affections accompanied by anxiety and apathy, menopausal depressions, dysphoria and depression in alcoholics and drug-addicts.

Dosage & Administration:
Adults: Usually 2 tablets daily; morning and noon. In severe cases the morning dose may be increased to 2 tablets.
Elderly: 1 tablet in the morning.
Maintenance dose: Usually 1 tablet in the morning. In cases of insomnia or severe restlessness additional treatment with a sedative in the acute phase is recommended.

Contraindications:
The immediate recovery phase after myocardial infarction, Defects in bundle-branch conduction, Untreated narrow angle glaucoma, Acute alcohol, barbiturate and opiate intoxications, Flupentixol-Melitracen should not be given to patients who have received a MAO-inhibitor within two weeks. Not recommended for excitable or overactive patients since its activating effect may lead to exaggeration of these characteristics.

Warning & Precautions:
If previously the patient has been treated with tranquilizers with sedative effect these should be withdrawn gradually.

Side Effects:
In the recommended doses side effects are rare. These could be transient restlessness and insomnia.

Drug interaction:
Flupentixol-melitracen may enhance the response to alcohol, barbiturates and other CNS depressants. Simultaneous administration of MAO-inhibitors may cause hypertensive crises. Neuroleptics and thymoleptics reduce the antihypertensive effect of guanethidine and similar acting compounds and thymoleptics enhance the effects of adrenaline and noradrenaline.

Use in Special group:
Use in pregnancy & lactation: Flupentixol-Melitracen should preferably not be given during pregnancy and lactation.

Packing:
Anfree Tablet: Each box contains 100's tablets in blister pack.



Norzin.....((Fluphenazine + Nortriptyline))




Norzin 

( Fluphenazine + Nortriptyline )
Therapeutic Group: Antipsychotic, Neurotonic & Sedative



Generic: Fluphenazine & Nortriptyline

Presentation:
Norzin Tablet: Each film coated Norzin tablet contains Fluphenazine hydrochloride BP 0.5 mg and Nortriptyline hydrochloride BP 10 mg.

Pharmacology:
Fluphenazine is a potent phenothiazine dervative. Nortriptyline is a tricyclic antidepressant having less sedative action. The combination stabilizes emotionally disturbed patients suffering from anxiety or depression or both. This drug helps to restore functional ability without developing any drug dependence.

Indication:
Emotional disturbance, anxiety, tension, fatigue, depression, headache, sleep disorder, bodyache, gastric problems etc.

Dosage & Administration:
Adult: 1 tablet 2 to 3 times daily.
Child: Not recommended.

Contraindications:
History of epilepsy or brain damage, blood dyscrasias, severe cardiac insufficiency, renal or liver damage, MAO inhibitors, children below 14 years of age.

Warning & Precautions:
Patients with glaucoma, prostate enlargement, cardiac failure and myocardial infarction. The drug may impair alertness and abilities to drive a car or operating machinery.

Side Effects:
Dryness of mouth, drowsiness, constipation, tachycardia, nasal congestion, blurred vision and excitement.

Use in Special group:
Pregnancy Safety in human pregnancy has not yet been established.
Lactation: Breast feeding is not recommended in women receiving Norzin.

Packing:
Norzin Tablet: Each box contains 250's tablets in blister pack.




Afrooooooooooooooooooooooooooooooooooooooooooooooz

Drug Index

Social Icons

 
Blogger Templates